Results 151 to 160 of about 34,488 (237)

Single-domain antibodies as potent inhibitors of clinically relevant <i>β</i>-lactamases in multidrug-resistant bacteria. [PDF]

Front Microbiol
Osset-Trenor P, Proft M, Pascual-Ahuir A.   +2 more
europepmc   +1 more source

NCY-1 β-Lactamase Activity Correlates With Antimicrobial Susceptibility of a Clinical Strain of Nocardia cyriacigeorgica. [PDF]

Microbiologyopen
Couston J, Le Marchand A, Hodille E, Genestet C, Joannard B, Feuillard J, Benito Y, Dumitrescu O, Blaise M.   +8 more
europepmc   +1 more source

Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in <i>Escherichia coli</i>. [PDF]

Antimicrob Agents Chemother
Stellfox ME, Doi Y.
europepmc   +1 more source

Small colony variants and cefiderocol resistance in clinical <i>Escherichia coli</i>: an <i>in vitro</i> mechanistic study. [PDF]

Front Microbiol
Syed MA, Pu D, Song R, Zhao J, Cao B.
europepmc   +1 more source

Flow cytometry enables rapid evaluation of novel, new and niche antimicrobial agents. [PDF]

Front Microbiol
Salisbury E, Mulroney K, Kopczyk MK, Paton T, Carson CF, Ho WS, Chakera A.   +6 more
europepmc   +1 more source

Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]

Emerg Microbes Infect
Rezzoug I, Bernabeu S, Ouacel K, Birer A, Jousset AB, Larouy-Maumus G, Bonnin RA, Emeraud C, Dortet L.   +8 more
europepmc   +1 more source

Quantitative high-throughput screening identifies small-molecule modulators of Wnt/β-catenin signaling. [PDF]

Front Pharmacol
Chen X, Yang S, Sakamuru S, Sukhawanit C, Wood S, Ooka M, Huang R, Xia M.   +7 more
europepmc   +1 more source

Zwitterionic Penicillin-Derived Sulfone Inhibitor for Combating β-Lactamase-Mediated Antibiotic Resistance. [PDF]

ChemMedChem
Rodríguez D, Lence E, Vázquez-Ucha JC, Beceiro A, González-Bello C.   +4 more
europepmc   +1 more source